DARE - Dare Bioscience - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DARE is currently covered by 5 analysts with an average price target of $1.53. This is a potential upside of $-1.38 (-47.42%) from yesterday's end of day stock price of $2.91.

Dare Bioscience's activity chart (see below) currently has 19 price targets and 34 ratings on display. The stock rating distribution of DARE is 90% BUY and 10% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 82.19% with an average time for these price targets to be met of 398.33 days.

Highest price target for DARE is $13, Lowest price target is $3, average price target is $7.5.

Most recent stock forecast was given by DOUGLAS TSAO from HCWAINWRIGHT on 01-Apr-2025. First documented stock forecast 17-Aug-2018.

Currently out of the existing stock ratings of DARE, 18 are a BUY (90%), 2 are a HOLD (10%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$9.09 (312.37%)

$12

1 months 10 days ago
(01-Apr-2025)

13/17 (76.47%)

$9.1 (313.79%)

198

Buy

$13

$10.09 (346.74%)

$5

8 months 25 days ago
(16-Aug-2024)

2/3 (66.67%)

$9.43 (264.15%)

149

Hold

$4

8 months 27 days ago
(14-Aug-2024)

1/1 (100%)

$-15.44 (-79.42%)

660

Buy

$3

$0.09 (3.09%)

11 months 26 days ago
(15-May-2024)

2/2 (100%)

$-1.32 (-30.56%)

135

Buy

$2

$-0.91 (-31.27%)

$9

1 years 8 months 11 days ago
(30-Aug-2023)

1/2 (50%)

$-6.52 (-76.53%)

713

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DARE (Dare Bioscience) average time for price targets to be met?

On average it took 398.33 days on average for the stock forecasts to be realized with a an average price target met ratio 82.19

Which analyst has the current highest performing score on DARE (Dare Bioscience) with a proven track record?

ZEGBEH JALLAH

Which analyst has the current lower performing score on DARE (Dare Bioscience) with a proven track record?

JASON KOLBERT

Which analyst has the most public recommendations on DARE (Dare Bioscience)?

Zegbeh Jallah works at CAPITAL ONE and has 20 price targets and 14 ratings on DARE

Which analyst is the currently most bullish on DARE (Dare Bioscience)?

Zegbeh Jallah with highest potential upside - $14.09

Which analyst is the currently most reserved on DARE (Dare Bioscience)?

Jason Kolbert with lowest potential downside - -$0.91

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?